Anzeige
Mehr »
Login
Mittwoch, 08.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0LD76 | ISIN: FR0004174233 | Ticker-Symbol: 830
Frankfurt
08.01.25
08:04 Uhr
17,550 Euro
-0,750
-4,10 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
BILENDI SA Chart 1 Jahr
5-Tage-Chart
BILENDI SA 5-Tage-Chart
RealtimeGeldBriefZeit
17,50017,95018:22
Dow Jones News
682 Leser
Artikel bewerten:
(2)

BILENDI: New AI-powered features for the research platform Bilendi Discuss

Finanznachrichten News

DJ BILENDI: New AI-powered features for the research platform Bilendi Discuss

BILENDI 
BILENDI: New AI-powered features for the research platform Bilendi Discuss 
10-Jan-2024 / 18:07 CET/CEST 
Dissemination of a French Regulatory News, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
 
 
New AI-powered features for the research platform Bilendi Discuss 
 
Paris, January 10, 2024 - Bilendi has added new features to Bilendi Discuss, the AI-supported multi-channel research 
platform. 
 
With an intuitive design, Bilendi Discuss ensures a smooth experience for researchers and participants. Research can be 
conducted either via social messaging apps or a web portal. 
Integrated into Bilendi Discuss, BARI, the Bilendi Artificial Research Intelligence, serves as a research assistant - 
enabling researchers to get more detailed verbatims in less time. 
 
Built-in AI-powered research assistant "BARI" supporting qualitative projects 
 
Bilendi Discuss is a well-established platform that has been tailored to the needs of researchers looking for a smooth 
tool with intuitive handling. It enables researchers to get deeper and more human insights than ever before. Using 
innovative in-house algorithms, proprietary AI and advanced prompt engineering techniques for ChatGPT, BARI was already 
able to deliver precise summaries and analysis of large amounts of data. Now BARI has become even more powerful. 
 
New feature: Professional automated moderation 
 
BARI has been levelled up with professional moderation skills: BARI adapts perfectly to the participants' responses in 
terms of content, writing style and length. The questions and follow-up questions asked are always relevant to the 
qualitative project and go far beyond a simple "tell us more". In real-time, BARI analyses the participant's first 
answer and picks up the relevant part to ask for more details. This leads to even more detailed and relevant verbatims. 
Acting as a tireless assistant, BARI supports researchers 24/7 with consistently professional and equal-to-human 
moderation skills. 
 
BARI can be tailored to the needs of the individual project: researchers can choose between a completely automatic or a 
semi-automatic moderation, which allows the researcher to validate the proposed question before sending it. This can 
also be changed in the course of a project, for example, by switching to automatic moderation during non-business 
hours. The level of intensity can also be adapted to define the number of follow-up questions BARI will ask. 
BARI is professional, flexible and always available. 
 
 
Marc Bidou, CEO and founder of Bilendi, states: 
"Our AI, BARI, has become a key feature of Bilendi Discuss. BARI has been developed to make the work of researchers 
easier, acting as a real assistant to them. First by providing reliable summaries and analysis and now also by 
autonomously moderating qualitative projects. For us, reliable, professional and comprehensive results are always the 
essential principles when developing new AI-features - and there are more to come." 
 
Next publication: 2023 revenues, February 27, 2024 (after market close) 
About Bilendi 
At a time when the volume, variety and speed of data transmitted and exchanged are increasing exponentially, Bilendi 
provides an innovative technological response to data collection, management and enhancement. Bilendi is thus 
positioned at the heart of data collection for two market segments: Technologies & Services for Market Research and 
Technologies & Services for Customer Engagement and Loyalty. 
 
The Group has an international reach, with operations in 13 countries: France, the UK, Germany, Italy, Belgium, Spain, 
Sweden, Finland, Denmark, Switzerland, the Netherlands, Morocco, Mauritius Island. The Group has also business activity 
in Austria and Norway. 
 
In 2021, Bilendi takes another major step in its development with the acquisition of Respondi, making it one of 
Europe's leading players in market research technology and data. In 2023, Bilendi launches Bilendi Discuss, an 
innovative new platform integrating AI functionalities, based on ChatGPT - a further demonstration of the Group's 
ability to position itself at the forefront of its market by offering its customers today's most advanced technologies 
and services. 
 
Bilendi posted sales of EUR61.5 million in 2022, up +39.5%, of which +6.3% on a pro-forma basis. 
The group is listed on Euronext Growth Paris. 
 
ISIN code: FR0004174233 - Mnemo code: ALBLD - PEA PME eligible. 
 
www.bilendi.com 
 
 
Contacts 
 
Bilendi 
Marc Bidou - Chairman and CEO 
Phone: +331 44 88 60 30 
m.bidou@bilendi.com 
 
ACTIFIN 
Analysts & Investors Relations        Press Relations 
 Foucauld Charavay/ Alexandre Commerot    Isabelle Dray 
 Foucauld.charavay@seitosei-actifin.com    idray@actifin.fr 
 Phone: +339 70 68 28 93           Phone: +331 56 88 11 29 
 
 

-----------------------------------------------------------------------------------------------------------------------

Regulatory filing PDF file File: New AI-powered features for the research platform Bilendi Discuss

=---------------------------------------------------- 
Language:    English 
Company:     BILENDI 
         4 rue de Ventadour 
         75001 PARIS 
         France 
E-mail:     contact.fr@bilendi.com 
Internet:    www.bilendi.com 
ISIN:      FR0004174233 
Euronext Ticker: ALBLD 
AMF Category:  Inside information / Other releases 
EQS News ID:   1812349 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------ 

1812349 10-Jan-2024 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1812349&application_name=news

(END) Dow Jones Newswires

January 10, 2024 12:07 ET (17:07 GMT)

© 2024 Dow Jones News
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.